Drug intelligence / Profile preview

ABE8e-SpWT base editor

Development stage
Preclinical
Lead developer
National Institutes of Health
Modality
CRISPR-Cas9 → CRISPR Systems → Programmable Nucleases → Gene Editing → Gene Therapies
Administration
Intravenous
01

Overview

ABE8e-SpWT is an adenine base editor (ABE) consisting of an evolved deoxyadenosine deaminase (ABE8e) fused to a catalytically impaired Streptococcus pyogenes Cas9 (SpCas9) protein, typically a nickase. This CRISPR-based tool is designed to perform precise A•T to G•C base pair conversions without inducing double-strand breaks. In the context of X-linked hyper-IgM syndrome (XHIM), ABE8e-SpWT is utilized to correct pathogenic mutations in the CD40L gene (such as the c.658C>T mutation) in patient-derived hematopoietic stem and progenitor cells (HSPCs) and T cells. By restoring functional CD40L expression, the therapy enables B cell class switching and immune reconstitution, offering a potentially curative approach with improved safety over traditional lentiviral gene addition strategies.

Other names
adenine base editor 8e-SpWTABE8e-SpCas9ABE-8e-SpCas9ABE 8e-SpCas9
02

Targets

DNA

Beyond the preview

Go deeper on ABE8e-SpWT base editor.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ABE8e-SpWT base editor.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call